Work

Pharmacologic advantage (PA) of intraperitoneal (IP) nab-paclitaxel in patients with advanced malignancies primarily confined to the peritoneal cavity.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.2553

Authors: Mihaela C. Cristea, Timothy W. Synold, Paul Henry Frankel, Saul E. Rivkin, Dean Lim, Vincent M. Chung, Joseph Chao, Mark Tsuneo Wakabayashi, Isaac Benjamin Paz, Ernest Soyoung Han, Paul Lin, Lucille A. Leong, Amy Hakim, Mary I. Carroll, Henry Openshaw, Neal Prakash, Thanh Hue Dellinger, Min S. Park, Robert Morgan

Institutions: City Of Hope National Medical Center, City of Hope, Beckman Research Institute

Language: English

Topic: Intraperitoneal and Appendiceal Malignancies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604614482

Cites:

Cited by: 11

Related to: 10